Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RNXT RenovoRx Inc
- Stocks
- Healthcare
- NASDAQ: RNXT
Price (delayed)
$1.18
Market cap
$43.16M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.4
Enterprise value
$28.76M
Highlights
The company's equity has surged by 194% QoQ
The quick ratio has soared by 127% from the previous quarter and by 112% YoY
The gross margin has contracted by 39% from the previous quarter
The net income has declined by 26% year-on-year and by 15% since the previous quarter
Key stats
What are the main financial stats of RNXT
Market
Valuations
Earnings
Shares outstanding
36.57M
Market cap
$43.16M
Enterprise value
$28.76M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.15
Price to sales (P/S)
154.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
119.83
Revenue
$240,000
Gross profit
$146,000
Operating income
-$11.6M
Net income
-$10.16M
EBIT
-$10.54M
EBITDA
-$10.51M
Free cash flow
-$10.32M
Per share
Balance sheet
Liquidity
EPS
-$0.4
EPS diluted
-$0.4
Free cash flow per share
-$0.33
Book value per share
$0.55
Revenue per share
$0.01
TBVPS
$0.51
Total assets
$16.01M
Total liabilities
$2.86M
Debt
$186,000
Equity
$13.16M
Working capital
$14.01M
Debt to equity
0.01
Current ratio
9.07
Quick ratio
8.54
Net debt/EBITDA
1.37
Margins
Efficiency
Dividend
EBITDA margin
-4,380%
Gross margin
60.8%
Net margin
-4,232.5%
Operating margin
-4,835%
Return on assets
-88%
Return on equity
-119.6%
Return on invested capital
N/A
Return on capital employed
-73.8%
Return on sales
-4,392.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RNXT stock price
How has the RenovoRx stock price performed over time
Intraday
6.31%
1 week
11.32%
1 month
14.56%
1 year
-19.18%
YTD
-8.53%
QTD
19.19%
Financial performance
How have RenovoRx's revenue and profit performed over time
Revenue
$240,000
Gross profit
$146,000
Operating income
-$11.6M
Net income
-$10.16M
Gross margin
60.8%
Net margin
-4,232.5%
The company's operating margin has surged by 81% QoQ
RenovoRx's net margin has surged by 79% QoQ
The gross margin has contracted by 39% from the previous quarter
The net income has declined by 26% year-on-year and by 15% since the previous quarter
Price vs fundamentals
How does RNXT's price correlate with its fundamentals
Growth
What is RenovoRx's growth rate over time
Valuation
What is RenovoRx stock price valuation
P/E
N/A
P/B
2.15
P/S
154.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
119.83
The EPS has grown by 44% YoY
The company's equity has surged by 194% QoQ
The P/B is 43% below the last 4 quarters average of 3.8
Efficiency
How efficient is RenovoRx business performance
The ROS has soared by 79% from the previous quarter
RNXT's ROA has soared by 56% YoY and by 13% from the previous quarter
RNXT's ROE is up by 23% QoQ
Dividends
What is RNXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RNXT.
Financial health
How did RenovoRx financials performed over time
The quick ratio has soared by 127% from the previous quarter and by 112% YoY
The current ratio has soared by 121% since the previous quarter and by 107% year-on-year
RenovoRx's debt is 99% lower than its equity
The company's equity has surged by 194% QoQ
The debt to equity has plunged by 80% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.